{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:45:21Z","timestamp":1787240721366,"version":"build-2736575974"},"reference-count":34,"publisher":"CMA Impact Inc.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["cmajo"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.9778\/cmajo.20170145","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T14:40:15Z","timestamp":1525099215000},"page":"E191-E196","source":"Crossref","is-referenced-by-count":21,"title":["The lesser of two evils: a qualitative study of quetiapine prescribing by family physicians"],"prefix":"10.9778","volume":"6","author":[{"given":"Martina","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Dornan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Pringsheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"382","published-online":{"date-parts":[[2018,4,30]]},"reference":[{"key":"2021101819450701000_6.2.E191.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.453"},{"key":"2021101819450701000_6.2.E191.2","doi-asserted-by":"crossref","first-page":"E225","DOI":"10.9778\/cmajo.20140009","article-title":"Dispensed prescriptions for quetiapine and other second-generation antipsychotics in Canada from 2005 to 2012: a descriptive study","volume":"2","author":"Pringsheim","year":"2014","journal-title":"CMAJ Open"},{"key":"2021101819450701000_6.2.E191.3","doi-asserted-by":"publisher","DOI":"10.2165\/11632030-000000000-00000"},{"key":"2021101819450701000_6.2.E191.4","doi-asserted-by":"publisher","DOI":"10.1177\/0004867412455234"},{"key":"2021101819450701000_6.2.E191.5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006135"},{"key":"2021101819450701000_6.2.E191.6","unstructured":"Maglione M Maher AR Hu J (2011) Off-label use of atypical antipsychotics: an update. Report no 11-EHC087-EF (Agency for Healthcare Research and Quality, Rockville (MD))."},{"key":"2021101819450701000_6.2.E191.7","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.60.9.1175"},{"key":"2021101819450701000_6.2.E191.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010861"},{"key":"2021101819450701000_6.2.E191.9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3928\/02793695-20130709-01","article-title":"Efficacy of quetiapine off-label uses: data synthesis","volume":"51","author":"Carney","year":"2013","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"2021101819450701000_6.2.E191.10","doi-asserted-by":"publisher","DOI":"10.1592\/phco.28.12.1443"},{"key":"2021101819450701000_6.2.E191.11","first-page":"617","article-title":"Adverse effects of antipsychotic medications","volume":"81","author":"Muench","year":"2010","journal-title":"Am Fam Physician"},{"key":"2021101819450701000_6.2.E191.12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-14-S1-S1"},{"key":"2021101819450701000_6.2.E191.13","doi-asserted-by":"publisher","DOI":"10.1177\/0706743716643823"},{"key":"2021101819450701000_6.2.E191.14","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.173501"},{"key":"2021101819450701000_6.2.E191.15","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.2.596"},{"key":"2021101819450701000_6.2.E191.16","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.12770"},{"key":"2021101819450701000_6.2.E191.17","unstructured":"Canadian Academy of Child and Adolescent Psychiatry, Canadian Academy of Geriatric Psychiatry, Canadian Psychiatric Association (2017) Thirteen things physicians and patients should question: Choosing Wisely Canada, Available: https:\/\/choosingwiselycanada.org\/psychiatry\/ . accessed 2018 Apr 20."},{"key":"2021101819450701000_6.2.E191.18","unstructured":"Evidence-based deprescribing algorithm for antipsychotics (Ontario Pharmacy Evidence Network, Kitchener (ON)) Available: www.open-pharmacy-research.ca\/evidence-based-deprescribing-algorithm-for-antipsychotics\/ . accessed 2017 Sept 1."},{"key":"2021101819450701000_6.2.E191.19","unstructured":"Tanni P Dunbabin D (2016) A guide to deprescribing antipsychotics (Consultant Pharmacy Services, Primary Health Tasmania, PHN Tasmania, Tasmania (AU)) Available: https:\/\/www.primaryhealthtas.com.au\/sites\/default\/files\/A%20Guide%20to%20Deprescribing%20Antipsychotics.pdf . accessed 2017 Sept 1."},{"key":"2021101819450701000_6.2.E191.20","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-016-3853-5"},{"key":"2021101819450701000_6.2.E191.21","doi-asserted-by":"publisher","DOI":"10.1136\/qhc.12.1.29"},{"key":"2021101819450701000_6.2.E191.22","doi-asserted-by":"publisher","DOI":"10.1258\/jrsm.2010.100104"},{"key":"2021101819450701000_6.2.E191.23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7309.378"},{"key":"2021101819450701000_6.2.E191.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.312.7036.949"},{"key":"2021101819450701000_6.2.E191.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2012.09.003"},{"key":"2021101819450701000_6.2.E191.26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11606-016-3916-7","article-title":"Barriers to Choosing Wisely in primary care: it\u2019s not just about \u201cthe money\u201d","volume":"32","author":"Rich","year":"2017","journal-title":"J Gen Intern Med"},{"key":"2021101819450701000_6.2.E191.27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000352"},{"key":"2021101819450701000_6.2.E191.28","doi-asserted-by":"crossref","unstructured":"King N Cassell C Symon G (2004) in Essential guide to qualitative methods in organizational research, Using templates in the thematic analysis of text, eds Cassell C Symon G (Sage, London (UK)), pp 256\u201370.","DOI":"10.4135\/9781446280119.n21"},{"key":"2021101819450701000_6.2.E191.29","first-page":"e103","article-title":"Strategic opportunities for effective optimal prescribing and medication management","volume":"16","author":"Sketris","year":"2009","journal-title":"Can J Clin Pharmacol"},{"key":"2021101819450701000_6.2.E191.30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.18773\/austprescr.2015.032","article-title":"Concerns about quetiapine","volume":"38","author":"Brett","year":"2015","journal-title":"Aust Prescr"},{"key":"2021101819450701000_6.2.E191.31","first-page":"1715","article-title":"Canadian physicians\u2019 attitudes about and preferences regarding clinical practice guidelines","volume":"156","author":"Hayward","year":"1997","journal-title":"CMAJ"},{"key":"2021101819450701000_6.2.E191.32","doi-asserted-by":"publisher","DOI":"10.2307\/3350142"},{"key":"2021101819450701000_6.2.E191.33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006544"},{"key":"2021101819450701000_6.2.E191.34","doi-asserted-by":"publisher","DOI":"10.1186\/s12909-017-1100-3"}],"container-title":["CMAJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.9778\/cmajo.20170145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T23:06:08Z","timestamp":1634598368000},"score":1,"resource":{"primary":{"URL":"http:\/\/cmajopen.ca\/lookup\/doi\/10.9778\/cmajo.20170145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,4,30]]},"published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.9778\/cmajo.20170145"],"URL":"https:\/\/doi.org\/10.9778\/cmajo.20170145","relation":{},"ISSN":["2291-0026"],"issn-type":[{"value":"2291-0026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}